Prosecution Insights
Last updated: April 19, 2026

Pxd Limited

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17434868 Methods of Screening and Compounds for Adverse Response to an Implant AFREMOVA, VERA 1653 Final Rejection Aug 30, 2021

Managing Pxd Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month